| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |